17 Aug Topical Corticosteroid – Risk of Withdrawal Reactions – Aspen
Posted at 11:42h
in
The following holders of certificates of registration (HCRs), Aspen Pharmacare, GlaxoSmithKline (Pty) Ltd and Glenmark Pharmaceuticals South Africa (Pty) Ltd, in collaboration with the South African Health Products Regulatory Authority (SAHPRA), wish to draw your attention to the following important safety information associated with topical corticosteroid containing medicines registered in South Africa. This safety issue was based on a review of the available evidence conducted by the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA).
2022 Aug
Download latest version
Document Number:
DHCPL
Version:
2
Date Updated:
16/08/2022
File Type:
pdf
Category:
Communication To Health Care Professionals